Results 1 to 10 of about 7,451,158 (356)
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Lancet, The, 2022 BACKGROUND
SGLT2 inhibitors are strongly recommended in guidelines to treat patients with heart failure with reduced ejection fraction, but their clinical benefits at higher ejection fractions are less well established.M. Vaduganathan, K. Docherty, B. Claggett, P. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, S. Inzucchi, M. Kosiborod, C. Lam, F. Martinez, Sanjiv J. Shah, Akshay S. Desai, J. McMurray, S. Solomon +13 moreexaly +2 more sources2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation, 2022 AIM
The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart ...P. Heidenreich, B. Bozkurt, D. Aguilar, L. Allen, Joni J. Byun, Monica Colvin, A. Deswal, M. Drazner, S. Dunlay, Linda R. Evers, J. Fang, S. Fedson, G. Fonarow, S. Hayek, Adrian F. Hernandez, P. Khazanie, M. Kittleson, Christopher S. Lee, M. Link, C. Milano, Lorraine C. Nnacheta, Alexander T. Sandhu, L. Stevenson, O. Vardeny, A. Vest, C. Yancy +25 moresemanticscholar +2 more sourcesHemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients
Transplantation Direct, 2022 Background. A pulmonary capillary wedge pressure (PCWP) >18 mm Hg following volume load has been proposed as a partition value for the detection of heart failure with preserved ejection fraction. As hemodynamic changes in filling pressures (FP) have been Monika Kobediona, MD, Jozef Bartunek, MD, PhD, Leen Delrue, PhD, Frederik Van Durme, MD, Chirik Wah Lau, MD, Ana Moya, PhD, Sofie Verstreken, MD, Ward Heggermont, MD, PhD, Riet Dierckx, MD, Marc Goethals, MD, Marc Vanderheyden, MD +10 moredoaj +1 more sourceEmpagliflozin in Heart Failure with a Preserved Ejection Fraction.
New England Journal of Medicine, 2021 BACKGROUND
Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction ...S. Anker, J. Butler, G. Filippatos, J. Ferreira, E. Bocchi, M. Böhm, H. Brunner-la Rocca, D. Choi, V. Chopra, E. Chuquiure-Valenzuela, N. Giannetti, J. Gómez-Mesa, S. Janssens, J. Januzzi, J. González-Juanatey, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, M. Senni, D. Sim, J. Špinar, I. Squire, S. Taddei, H. Tsutsui, S. Verma, D. Vinereanu, Jian Zhang, P. Carson, Carolyn S. P. Lam, N. Marx, C. Zeller, N. Sattar, W. Jamal, S. Schnaidt, J. Schnee, M. Brueckmann, S. Pocock, F. Zannad, M. Packer +40 moresemanticscholar +1 more sourceSelection of Comprehensive Assessment Categories Based on the International Classification of Functioning, Disability, and Health for Elderly Patients with Heart Failure: A Delphi Survey among Registered Instructors of Cardiac Rehabilitation
Occupational Therapy International, 2021 The development of a comprehensive assessment tool based on the International Classification of Functioning, Disability, and Health (ICF) for elderly patients with heart failure is urgently required.Shigehito Shiota, Makiko Naka, Toshiro Kitagawa, Takayuki Hidaka, Naoki Mio, Kana Kanai, Mariko Mochizuki, Hiroaki Kimura, Yasuki Kihara +8 moredoaj +1 more source2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Journal of Heart Failure, 2022 Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P. Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor Aboyans (France), Stamatis Adamopoulos (Greece), Stefan D.T. McDonagh, M. Metra, M. Adamo, R. Gardner, A. Baumbach, M. Böhm, H. Burri, J. Butler, J. Čelutkienė, O. Chioncel, J. Cleland, A. Coats, M. Crespo-Leiro, D. Farmakis, M. Gilard, S. Heymans, A. Hoes, T. Jaarsma, E. Jankowska, M. Lainščak, C. Lam, A. Lyon, J. McMurray, A. Mebazaa, R. Mindham, C. Muneretto, Massimo Francesco Piepoli, S. Price, G. Rosano, F. Ruschitzka, Anne Kathrine Skibelund +30 moresemanticscholar +1 more sourceHeart failure [PDF]
Nursing Standard, 2014 Essential facts Heart failure affects about 900,000 people in the UK. The condition can affect people of all ages, but it is more common in older people, with more than half of all patients over the age of 75. It is caused by the heart failing to pump enough blood around the body at the right pressure, usually because the heart muscle has become too ...Yanggan Wang, Yanzong Yang, Xun Aiopenaire +5 more sourcesDapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
New England Journal of Medicine, 2022 BACKGROUND
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death among patients with chronic heart failure and a left ventricular ejection fraction of 40% or less.S. Solomon, J. McMurray, B. Claggett, R. D. de Boer, D. DeMets, Adrian F. Hernandez, S. Inzucchi, M. Kosiborod, C. Lam, F. Martinez, Sanjiv J. Shah, Akshay S. Desai, P. Jhund, J. Bělohlávek, C. Chiang, C. Borleffs, J. Comín-Colet, D. Dobreanu, J. Drożdż, J. Fang, M. Alcocer-Gamba, Waleed Al habeeb, Yaling Han, Jose Walter Cabrera Honorio, S. Janssens, T. Katova, M. Kitakaze, B. Merkely, E. O’Meara, J. Saraiva, S. Tereshchenko, J. Thierer, M. Vaduganathan, O. Vardeny, S. Verma, V. Pham, U. Wilderäng, Natalia Zaozerska, E. Bachus, D. Lindholm, Magnus Petersson, A. Langkilde +41 moresemanticscholar +1 more sourceThe EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis [PDF]
, 2003 The European Society of Cardiology (ESC) has published guidelines for the investigation of patients with suspected heart failure and, if the diagnosis is proven, their subsequent management.Aguilar, JC, Cleland, JGF, Cohen-Solal, A, Dietz, R, Eastaugh, J, Follath, F, Freemantle, N, Gavazzi, A, Hobbs, R, Komajda, M, Korewicki, J, Madeira, HC, Mason, J, Moiseyev, VS, Preda, I, Study Grp Diag Working Grp Heart F,, Swedberg, K, van Gilst, WH, Widimsky, J +18 morecore +12 more sources2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation, 2022 AIM
The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart ...P. Heidenreich, B. Bozkurt, D. Aguilar, L. Allen, Joni J. Byun, Monica Colvin, A. Deswal, M. Drazner, S. Dunlay, Linda R. Evers, J. Fang, S. Fedson, G. Fonarow, S. Hayek, Adrian F. Hernandez, P. Khazanie, M. Kittleson, Christopher S. Lee, M. Link, C. Milano, Lorraine C. Nnacheta, Alexander T. Sandhu, L. Stevenson, O. Vardeny, A. Vest, C. Yancy +25 moresemanticscholar +2 more sources
